AZGP1 and intrahepatic cholangiocarcinoma: In addition, to investigate whether lenvatinib inhibited EMT in ICC cells by activating AZGP1, we found that downregulated AZGP1 expression could partially restore the migration and invasion inhibited by the addition of lenvatinib (Fig. 5E).